IMMUNOGLOBULIN A - ANVISA Registration 80158990311
Access comprehensive regulatory information for IMMUNOGLOBULIN A in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80158990311 and manufactured by RANDOX LABORATORIES LTD.. The registration is held by RANDOX BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including PHADIA AB, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80158990311
25351640667201828
05257628000190
Company Information
Dates and Status
Dec 03, 2018
VIGENTE
09/18/2025 19:00:01
IMUNOGLOBULINA A
Imunoglobulina A (IgA)
DIAGAM S.A.
81546350085
Sep 01, 2025
IMUNOGLOBULINA A
Famรญlia Imunoglobulina A (IgA)
KATAL BIOTECNOLOGICA INDรSTRIA E COMรRCIO LTDA
10377390319
Jun 09, 2025
IMUNOGLOBULINA A
IgA Conjugate
ALIVEDX SUISSE SA
81504790488
May 12, 2025
IMUNOGLOBULINA A
Imunoglobulina A (IgA)
DIAGAM S.A.
81546350078
Jan 06, 2025
IMUNOGLOBULINA A
Famรญlia Imunoglobulina A (IgA)
BIOSYSTEMS S.A.
80367750170
Jan 23, 2023

